Rafferty Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.42M | Sell |
|
|||||
|
2025
Q1 | $9.9M | Sell |
|
|||||
|
2024
Q4 | $10.2M | Sell |
|
|||||
|
2024
Q3 | $9.47M | Buy |
|
|||||
|
2024
Q2 | $10.2M | Buy |
|
|||||
|
2024
Q1 | $9.59M | Sell |
|
|||||
|
2023
Q4 | $9.97M | Sell |
|
|||||
|
2023
Q3 | $6.62M | Buy |
|
|||||
|
2023
Q2 | $7.22M | Buy |
|
|||||
|
2023
Q1 | $6.82M | Sell |
|
|||||
|
2022
Q4 | $30.6M | Buy |
|
|||||
|
2022
Q3 | $4.28M | Buy |
|
|||||
|
2022
Q2 | $2.23M | Sell |
|
|||||
|
2022
Q1 | $4.54M | Buy |
|
|||||
|
2021
Q4 | $3.1M | Buy |
|
|||||
|
2021
Q3 | $2.51M | Buy |
|
|||||
|
2021
Q2 | $2.35M | Sell |
|
|||||
|
2021
Q1 | $3.31M | Buy |
|
|||||
|
2020
Q4 | $775K | Sell |
|
|||||
|
2020
Q3 | $1.25M | Buy |
|
|||||
|
2020
Q2 | $861K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $1.43M | Sell |
|
|||||
|
2019
Q3 | $2.95M | Sell |
|
|||||
|
2019
Q2 | $4.11M | Buy |
|
|||||
|
2019
Q1 | $3.95M | Buy |
|